Annual EBIT
-$6.30M$65.51M-110.65%
Summary
- Current Value
- As of today, RGEN annual EBIT is -$6.30M, down -110.65% on
- Historical Performance
- RGEN annual EBIT is down -103.82% over the past 3 years, and down -117.79% over the past 5 years
- All-Time High Comparison
- RGEN annual EBIT is currently -102.86% below its historical high of $220.30M set on
- 3-Year Low Comparison
- RGEN annual EBIT is at its 3-year low
- Sector Comparison
- RGEN annual EBIT is higher than 68.73% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$6.30M | -110.7% | -103.8% | -117.8% | -28.7% | |
| Quarterly EBIT | $16.35M | +482.0% | -74.5% | -25.6% | +3005.2% | |
| TTM EBIT | $48.29M | +73.8% | -80.5% | -18.6% | +2912.5% | |
| Price | $166.82 | +7.8% | +5.0% | -19.9% | +3717.4% | |
| PE Ratio | 6,465.89 | – | +10000.0% | +3352.7% | +1379.6% | |
| Annual Revenue | $634.44M | +0.3% | -5.4% | +134.8% | +2925.3% | |
| Annual EPS | -$0.46 | -172.2% | -120.4% | -204.8% | -250.8% | |
| Annual EBITDA | -$6.30M | -104.9% | -103.1% | -111.2% | -79.2% | |
| Annual Net Income | -$25.51M | -171.7% | -119.9% | -219.2% | -527.8% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $220.30M | N/A | -102.9% |
| 5Y | $220.30M | -102.9% | |
| All | $220.30M | -102.9% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$6.30M | at low | |
| 5Y | -$6.30M | at low | |
| All | -$20.30M | +69.0% |
EBIT History
FAQ
What is the current annual EBIT of RGEN?
As of today, RGEN annual EBIT is -$6.30M
What is 1-year change in RGEN annual EBIT?
RGEN annual EBIT is down -110.65% year-over-year
What is 3-year change in RGEN annual EBIT?
RGEN annual EBIT is down -103.82% over the past 3 years
How far is RGEN annual EBIT from its all-time high?
RGEN annual EBIT is currently -102.86% below its historical high of $220.30M set on December 31, 2022
How does RGEN annual EBIT rank versus sector peers?
RGEN annual EBIT is higher than 68.73% of companies in Healthcare sector
When is RGEN next annual earnings release?
The next annual earnings release for RGEN is on
Quarterly EBIT
$16.35M$8.23M+101.37%
Summary
- Current Value
- As of today, RGEN quarterly EBIT is $16.35M, up +101.37% on
- Historical Performance
- RGEN quarterly EBIT is up +481.99% year-over-year, and down -74.46% over the past 3 years
- All-Time High Comparison
- RGEN quarterly EBIT is currently -76.61% below its historical high of $69.89M set on
- 3-Year Low Comparison
- RGEN quarterly EBIT is +481.99% above its 3-year low of -$4.28M reached on
- Sector Comparison
- RGEN quarterly EBIT is higher than 83.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | $16.35M | +101.4% | +482.0% | -74.5% | -25.6% | |
| Annual EBIT | -$6.30M | – | -110.7% | -103.8% | -117.8% | |
| TTM EBIT | $48.29M | +74.6% | +73.8% | -80.5% | -18.6% | |
| Price | $166.82 | +12.1% | +7.8% | +5.0% | -19.9% | |
| PE Ratio | 6,465.89 | +12.1% | – | +10000.0% | +3352.7% | |
| Quarterly Revenue | $188.81M | +3.5% | +21.9% | -6.0% | +100.7% | |
| Quarterly EPS | $0.26 | +0.3% | +2354.7% | -62.6% | -3.1% | |
| Quarterly EBITDA | $36.36M | -15.8% | +111.7% | -52.6% | +26.8% | |
| Quarterly Net Income | $14.91M | +0.3% | +2380.0% | -63.1% | +2.5% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $16.35M | at high | |
| 3Y | $31.71M | N/A | -48.5% |
| 5Y | $69.89M | -76.6% | |
| All | $69.89M | -76.6% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $8.12M | +101.4% | |
| 3Y | -$4.28M | +482.0% | |
| 5Y | -$4.28M | +482.0% | |
| All | -$10.90M | +250.0% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of RGEN?
As of today, RGEN quarterly EBIT is $16.35M
What is RGEN quarterly EBIT most recent change?
RGEN quarterly EBIT was up +101.37% on September 30, 2025
What is 1-year change in RGEN quarterly EBIT?
RGEN quarterly EBIT is up +481.99% year-over-year
How far is RGEN quarterly EBIT from its all-time high?
RGEN quarterly EBIT is currently -76.61% below its historical high of $69.89M set on June 30, 2022
How does RGEN quarterly EBIT rank versus sector peers?
RGEN quarterly EBIT is higher than 83.91% of companies in Healthcare sector
When is RGEN next earnings release?
The next earnings release for RGEN is on
TTM EBIT
$48.29M$20.63M+74.58%
Summary
- Current Value
- As of today, RGEN TTM EBIT is $48.29M, up +74.58% on
- Historical Performance
- RGEN TTM EBIT is up +73.76% year-over-year, and down -80.49% over the past 3 years
- All-Time High Comparison
- RGEN TTM EBIT is currently -80.49% below its historical high of $247.48M set on
- 3-Year Low Comparison
- RGEN TTM EBIT is +98.68% above its 3-year low of $24.31M reached on
- Sector Comparison
- RGEN TTM EBIT is higher than 83.82% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | $48.29M | +74.6% | +73.8% | -80.5% | -18.6% | |
| Annual EBIT | -$6.30M | – | -110.7% | -103.8% | -117.8% | |
| Quarterly EBIT | $16.35M | +101.4% | +482.0% | -74.5% | -25.6% | |
| Price | $166.82 | +12.1% | +7.8% | +5.0% | -19.9% | |
| PE Ratio | 6,465.89 | +12.1% | – | +10000.0% | +3352.7% | |
| TTM Revenue | $707.89M | +5.0% | +11.7% | -11.7% | +116.4% | |
| TTM EPS | $0.03 | +110.3% | +117.5% | -99.1% | -96.9% | |
| TTM EBITDA | $158.18M | +13.8% | +35.8% | -46.4% | +86.3% | |
| TTM Net Income | $1.74M | +112.6% | +121.5% | -99.0% | -96.0% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $48.29M | at high | |
| 3Y | $229.48M | N/A | -79.0% |
| 5Y | $247.48M | -80.5% | |
| All | $247.48M | -80.5% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $24.31M | N/A | +98.7% |
| 3Y | $24.31M | +98.7% | |
| 5Y | $24.31M | +98.7% | |
| All | -$22.10M | +318.5% |
TTM EBIT History
FAQ
What is the current TTM EBIT of RGEN?
As of today, RGEN TTM EBIT is $48.29M
What is RGEN TTM EBIT most recent change?
RGEN TTM EBIT was up +74.58% on September 30, 2025
What is 1-year change in RGEN TTM EBIT?
RGEN TTM EBIT is up +73.76% year-over-year
How far is RGEN TTM EBIT from its all-time high?
RGEN TTM EBIT is currently -80.49% below its historical high of $247.48M set on September 30, 2022
How does RGEN TTM EBIT rank versus sector peers?
RGEN TTM EBIT is higher than 83.82% of companies in Healthcare sector
When is RGEN next earnings release?
The next earnings release for RGEN is on
EBIT Formula
EBIT = − −
Data Sources & References
- RGEN Official Website www.repligen.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/730272/000119312525252385/0001193125-25-252385-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/730272/000095017025038999/0000950170-25-038999-index.htm
- RGEN Profile on Yahoo Finance finance.yahoo.com/quote/RGEN
- RGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgen